Stay updated on CDX-0159 Phase 1 Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 Phase 1 Clinical Trial page.

Latest updates to the CDX-0159 Phase 1 Clinical Trial page
- ChecktodayChange DetectedRevision: v3.3.4 is now displayed on the page, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now features a Locations section listing Kansas as a site, and the revision updated to v3.3.3; the old Kansas Locations section and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.3%

- Check50 days agoChange DetectedThe page now shows Revision: v3.3.2 instead of v3.3.1, a minor update in the footer that does not alter study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.3.1 was added and v3.2.0 was removed; this appears to be a site/build update that does not alter the study details, eligibility criteria, or data shown on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe government funding/operating status notice was removed from the page. This change does not affect the study details, eligibility criteria, or contacts listed.SummaryDifference0.5%

- Check79 days agoChange DetectedThe page shows the same study details with a redesigned layout; core information such as the title, conditions, intervention, eligibility criteria, and key dates remains unchanged.SummaryDifference0.5%

Stay in the know with updates to CDX-0159 Phase 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 Phase 1 Clinical Trial page.